2024/04/08 更新

写真a

ヒラヤマ クミコ
平山 公美子
HIRAYAMA Kumiko
担当
大学院医学研究科 臨床医科学専攻 講師
医学部 医学科
職名
講師
所属
医学研究院

担当・職階

  • 大学院医学研究科 臨床医科学専攻 

    講師  2024年04月 - 継続中

  • 大学院医学研究科 臨床医科学専攻 

    助教  2022年04月 - 2024年03月

  • 医学部 医学科 

    講師  2024年04月 - 継続中

  • 医学部 医学科 

    助教  2022年04月 - 2024年03月

論文

  • Selective retina therapy (SRT) for macular serous retinal detachment associated with tilted disc syndrome. 査読

    Kumiko Hirayama, M.D., Ph.D.; Manabu Yamamoto, M.D., Ph.D.; Takeya Kohno, M.D., Ph.D.; Akika Kyo, M.D.; Dirk Theisen-Kunde; Ralf Brinkmann; Yoko Miura, M.D., Ph.D.; Shigeru Honda, M.D., Ph.D.

    Graefe's Archive for Clinical and Experimental Ophthalmology   259   387 - 393   2021年09月

     詳細を見る

    担当区分:筆頭著者   掲載種別:研究論文(学術雑誌)   共著区分:共著   国際・国内誌:国際誌  

    Purpose Tilted disc syndrome (TDS) may be associated with a macular serous retinal detachment (MSRD). However, ideal therapy for this complication is still unestablished yet to date. The purpose of this study is to investigate the effect of selective retina therapy (SRT) for MSRD associated with TDS. Methods This retrospective study included 11 eyes of 10 patients (1 male and 9 females), who were treated with SRT for MSRD associated with TDS, and observed at least 12 months after treatment. The mean age was 56 years old (range 44–66). An SRT laser (527 nm, 1.7 μs, 100 Hz; Medical Laser Center Lübeck, Germany) was used for treatment. The changes of best-corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) were examined. Subfoveal curve height (SFCH) was calculated at baseline. Results The mean follow-up period was 24.4 months (range 12–48 months). The mean BCVA (logMAR), CMT, and CCT changed from 0.03 ± 0.10, 324 ± 82 μm, and 194 ± 68 μm preoperatively to 0.07 ± 0.17, 274 ± 94 μm, and 188 ± 65 μm at final follow-up, respectively, with significant difference on CMT (BCVA: p = 0.44, CMT: p < 0.05, CCT: p = 0.21). The MSRD disappeared in 6 eyes (55%) and the average number of SRT irradiations until resolution of MSRD was 2.6 times (range 1–5 times). There was no significant association between SFCH and resolution of MSRD (p = 0.19). Conclusions SRT may promote absorption of MSRD and maintenance of BCVA for TDS. Randomized and prospective clinical studies are needed to evaluate the effectiveness of SRT for MSRD associated with TDS.

書籍等出版物

  • すべて見せます!患者説明同意書マニュアル

    平山公美子( 担当: 単著)

    医学書院  2020年10月 

     詳細を見る

    担当ページ:蛍光眼底造影検査  

科研費獲得実績

  • 中心性漿液性網脈絡膜症における内因性コルチゾールと遺伝的感受性の関連

    若手研究  2025年

  • 中心性漿液性網脈絡膜症における内因性コルチゾールと遺伝的感受性の関連

    若手研究  2024年